Advanced Enzyme Technologies Ltd

Advanced Enzyme Technologies Ltd share price softened by 1.88% to Rs 324.4 after the company's net profit declined by 14.72% to Rs 38.59 crore, while revenue from operations slipped slightly by 6.68% to Rs 189.79 crore in Q2FY26 over Q1FY26. The market capitalization of Biotechnology industry group stocks on BSE stood at Rs 48729.77 crore, tanking 25.06%. It has improved by 3.63% over last one week and ticked higher by 5.61% in last one month while the market capitalization of Advanced Enzyme Technologies Ltd has inched up 2.98% and 9.17% in the same period respectively. Profit before tax (PBT) of Advanced Enzyme Technologies Ltd stood at Rs 53.53 crore in Q2 FY26, slipping 2.50% year-on-year, and retreating 10.48% quarter-on-quarter. EBITDA came in at Rs 38 crore, crashing by 20.24% YoY and nosediving by 32.23% sequentially. Total expenses marginally dropped 1.08% to Rs 148.7 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 54.5 crore, marginally falling by 2.61% YoY, while employee benefits expense was at Rs 44.55 crore, ticking higher by 6.22% YoY. For the TTM ended FY26, revenue from operations improved 17.09% to Rs 745.76 crore, while net profit saw a strong growth of 29.59% to Rs 173.61 crore, compared to previous TTM. EBITDA soared by 16393% to Rs 194.23 crore, and PBT witnessed a strong rise of 24.11% to Rs 232.54 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 156.78 crore in FY26, as against Rs 142.5 crore in FY25. Advanced Enzyme Technologies Ltd gained 3.96% in last one year, significantly outperforming the benchmark BSE Sensex which has softened by 2.63% during the same period.

Advanced Enzyme Techs. announced that the Annual General Meeting(AGM) of the company will be held on 31 July 2026.

Advanced Enzyme Technologies announced the cessation of Rajshree Patel (DIN - 08761022) on completion of her second term as Independent Director of the company on 11 June 2026.

Advanced Enzyme Techs. announced that the Board of Directors of the Company at its meeting held on 9 May 2026, inter alia, have recommended the final dividend of Rs 1.35 per equity Share (i.e. 67.5%) , subject to the approval of the shareholders.

Net profit of Advanced Enzyme Technologies rose 62.24% to Rs 42.96 crore in the quarter ended March 2026 as against Rs 26.48 crore during the previous quarter ended March 2025. Sales rose 21.65% to Rs 203.37 crore in the quarter ended March 2026 as against Rs 167.18 crore during the previous quarter ended March 2025. For the full year,net profit rose 28.68% to Rs 168.72 crore in the year ended March 2026 as against Rs 131.12 crore during the previous year ended March 2025. Sales rose 17.09% to Rs 745.76 crore in the year ended March 2026 as against Rs 636.91 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales203.37167.18 22 745.76636.91 17 OPM %31.0927.28 -30.7230.53 - PBDT69.8953.54 31 261.27223.92 17 PBT59.6943.46 37 221.18187.36 18 NP42.9626.48 62 168.72131.12 29 Powered by Capital Market - Live

Advanced Enzyme Technologies announced that ICRA has rated the company's debt facilities of Rs 100 crore at ICRA AA-; Stable; ICRA A1+. Powered by Capital Market - Live

Net profit of Advanced Enzyme Technologies rose 12.88% to Rs 42.50 crore in the quarter ended December 2025 as against Rs 37.65 crore during the previous quarter ended December 2024. Sales rose 1.68% to Rs 171.95 crore in the quarter ended December 2025 as against Rs 169.11 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales171.95169.11 2 OPM %28.7032.67 - PBDT57.2561.99 -8 PBT47.0453.02 -11 NP42.5037.65 13 Powered by Capital Market - Live

Advanced Enzyme Techs. will hold a meeting of the Board of Directors of the Company on 31 January 2026.Powered by Capital Market - Live

Total expenditure for the period under review added up to Rs 135.27 crore, up 19.2% YoY. This was primarily due to higher raw material costs (up 24.8% YoY), higher employee expenses (up 10.8% YoY) and higher other expenses (up 14.3% YoY). Profit before tax in Q2 FY26 stood at Rs 59.54 crore, up by 41% from Rs 42.21 crore recorded in Q2 FY25. Advanced Enzyme Technologies is a research driven company with global leadership in the manufacturing of enzymes and probiotics. The company provides eco-safe solutions to a wide variety of industries like human health care and nutrition, animal nutrition, baking, fruit & vegetable processing, brewing & malting, grain processing, protein modification, dairy processing, specialty applications, textile processing and others. Its aim is to replace traditionally used chemicals with eco-friendly enzymatic solutions. Powered by Capital Market - Live

Net profit of Advanced Enzyme Technologies rose 31.98% to Rs 43.33 crore in the quarter ended September 2025 as against Rs 32.83 crore during the previous quarter ended September 2024. Sales rose 26.30% to Rs 184.53 crore in the quarter ended September 2025 as against Rs 146.10 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales184.53146.10 26 OPM %32.5529.03 - PBDT69.6251.10 36 PBT59.5442.21 41 NP43.3332.83 32 Powered by Capital Market - Live